Redline Pharmacy Recalls Daptomycin Injectable Due to Processing Control Issues
Redline Pharmacy Solutions is recalling 16 doses of Daptomycin 500MG injectable sold in Nebraska due to a lack of processing controls.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score when no specific injuries or illnesses are reported in the source text.
Plain-English summary
Redline Pharmacy Solutions is recalling 16 doses of Daptomycin, 500MG in 0.9% NACL 100ML Injectable. The recall was initiated because of a lack of processing controls at the facility.
The affected product was sold to patients in Nebraska. The specific lots involved are 02242020@3 and 02242020@9. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Patients who have received this medication should contact their healthcare provider or the recalling firm for further instructions on what to do with the product.
The recalled product
- Product
- Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
- Manufacturer
- Redline Pharmacy Solutions
- Category
- Drug — Injectable
- Hazard
- Affected units
- 16
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots 02242020@3
- 02242020@9
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 6 recalled by Redline Pharmacy Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Redline Pharmacy Solutions
See all →- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Controls
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- ModerateRedline Pharmacy Recalls Acetylcysteine Ophthalmic Solution Due to Processing Controls
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
Same hazard · processing control
See all →- ModerateParegoric Alternate Elixir Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateTestosterone Gel Recalled by Florida Pharmacy for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateHydrocortisone Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateDiethylstilbestrol Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateErgotamine Tartrate and Caffeine Suppositories Recalled for Processing Control Issues
FDA (Drugs) · 2020-04-22